Aerospace Group:

Homeland Security

PharmAthene Expects up to $1.6M for Anthrax Therapeutic

DDN

Wednesday, January 23rd, 2008

SHARE:

PharmAthene, Inc. [PIP] expects to receive up to $1.6 million from the Pentagon for continued development of its Anthrax therapeutic Valortim after Congress included the funds in the FY '08 Defense Appropriations Act. Preclinical studies of Valortim have shown that the drug could be used as a prophylactic-post exposure but prior to the emergence of symptoms-and as a therapeutic-once symptoms become evident. Total government spending on Valortim the last four fiscal years, excluding the FY '08 appropriations, is $23 million.

Congress

Munitions Fired Represent Most of $25 Billion Spent By Pentagon on Iran War So Far

Munitions fired in the two-month old “Operation Epic Fury” against Iran represent most of the $25 billion cost the Pentagon has incurred thus far in the conflict, the acting Defense […]

Congress

Slotkin: Pentagon Should Use Anthropic’s Mythos To Spot Cyber Security Gaps

The Pentagon should be using Anthropic‘s recently announced Mythos artificial intelligence model to spot gaps in cyber security, Sen. Elissa Slotkin (D-Mich.) said on Tuesda. “I think the thing that […]

Budd And Shaheen Bill Would Authorize 329 F-15EX Fighters

Two members of the Senate Armed Services Committee (SASC), Sen. Ted Budd (R-N.C.) and Sen. Jeanne Shaheen (D-N.H.), have introduced the Airpower Acceleration Act, which would authorize multi-year procurements of […]

Congress

HASC’s Wittman Sees ‘Challenging’ Push For $350B In Reconciliation Funds, Wants Sustained Defense Increase

NATIONAL HARBOR, Md.– Congress’ work to pass $350 billion in reconciliation funds to support the Trump administration’s push for a $1.5 trillion fiscal year 2027 defense topline is “going to […]